Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ATTR
Marketing
Alnylam embarks on campaign to drive hATTR amyloidosis diagnoses
Alnylam's new campaign encourages people to talk about their family health history in hopes of identifying hereditary diseases they may be carrying.
Andrea Park
Mar 13, 2024 10:30am
Alnylam's last-minute Amvuttra trial change raises doubts
Feb 15, 2024 11:26am
FDA spurns Alnylam's Onpattro in ATTR-CM despite adcomm backing
Oct 9, 2023 9:54am
Pfizer's tafamidis will hold its own against new meds: analysts
Sep 18, 2023 3:05pm
Alnylam wins expert backing for Onpattro in rare heart disease
Sep 13, 2023 5:30pm
FDA casts doubt on Alnylam's Onpattro in ATTR-CM
Sep 11, 2023 11:15am